…
Newtopia Inc. operates as a tech-enabled whole health platform primarily in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. Newtopia Inc. was incorporated in 2008 and is headquartered in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -6.60M | -7.70M | -7.65M | -7.73M | -10.14M |
| Net income | -6.60M | -7.70M | -7.65M | -7.73M | -10.14M |
| Selling general administrative | 7.43M | 10.90M | 11.61M | 8.65M | 6.95M |
| Gross profit | 5.28M | 6.03M | 5.07M | 5.50M | 1.97M |
| Reconciled depreciation | 0.83M | 0.28M | 0.25M | 0.27M | 0.24M |
| Ebit | - | - | -7.21M | -6.86M | -7.73M |
| Ebitda | - | -7.02M | -7.21M | -7.09M | -7.10M |
| Operating income | -2.60M | -6.44M | -7.21M | -6.86M | -7.73M |
| Interest expense | 0.94M | 0.39M | 0.19M | 0.38M | 2.80M |
| Net interest income | -1.60M | -0.91M | -0.43M | -0.39M | -2.81M |
| Total revenue | 9.78M | 11.17M | 10.46M | 11.42M | 6.11M |
| Total operating expenses | 12.38M | 17.60M | 17.67M | 18.27M | 13.84M |
| Cost of revenue | 4.51M | 5.14M | 5.38M | 5.91M | 4.14M |
| Total other income expense net | -2.41M | -0.35M | -0.01M | -0.49M | 0.40M |
| Net income from continuing ops | -6.60M | -7.70M | -7.65M | -7.73M | -10.14M |
| Net income applicable to common shares | - | - | -7.65M | -7.73M | -10.14M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 2.33M | 5.94M | 5.51M | 7.90M | 5.63M |
| Intangible assets | - | 3.24M | - | - | - |
| Other current assets | - | - | 0.16M | 0.23M | - |
| Total liab | 11.75M | 11.48M | 7.35M | 3.70M | 16.84M |
| Total stockholder equity | -9.42M | -5.53M | -1.84M | 4.20M | -11.21M |
| Other current liab | - | - | 0.20M | 0.05M | 2.13M |
| Common stock | - | - | 45.18M | 44.65M | 4.64M |
| Capital stock | 49.40M | 47.98M | 45.18M | 44.65M | 17.65M |
| Retained earnings | -72.97M | -66.37M | -58.67M | -51.02M | -43.20M |
| Cash | 0.39M | 0.35M | 0.81M | 4.67M | 2.39M |
| Total current liabilities | 10.36M | 10.41M | 4.80M | 2.62M | 15.96M |
| Net debt | 9.49M | 7.96M | 3.70M | - | 1.61M |
| Short long term debt | 8.49M | 7.23M | 2.33M | - | 3.99M |
| Other stockholder equity | - | - | - | 0.53M | 9.16M |
| Property plant equipment | - | - | 0.44M | 0.68M | 0.93M |
| Total current assets | 2.33M | 2.70M | 2.82M | 6.74M | 4.70M |
| Net tangible assets | - | - | -4.10M | 4.13M | -24.22M |
| Net receivables | 1.33M | 1.49M | 1.38M | 1.09M | 1.25M |
| Long term debt | 1.39M | 1.07M | 2.18M | - | - |
| Inventory | 0.12M | 0.33M | 0.13M | 0.28M | 0.60M |
| Accounts payable | 1.83M | 2.58M | 1.39M | 1.58M | 1.25M |
| Non current assets total | 0.00M | 3.24M | 2.69M | 0.75M | 0.93M |
| Capital lease obligations | 0.00M | 0.54M | 0.67M | 0.88M | 1.04M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -0.00M | -0.99M | -2.15M | -0.09M | -0.16M |
| Change to liabilities | - | - | -0.03M | 0.55M | 1.05M |
| Total cashflows from investing activities | - | - | -2.15M | -0.09M | -0.16M |
| Net borrowings | 0.73M | - | 4.55M | -0.30M | -0.36M |
| Total cash from financing activities | 2.31M | 6.44M | 4.23M | 7.17M | 6.65M |
| Change to operating activities | - | - | 0.13M | -0.00M | -0.20M |
| Net income | -6.60M | -7.70M | -7.65M | -7.73M | -10.14M |
| Change in cash | 0.04M | -0.47M | -3.86M | 2.29M | 0.96M |
| Begin period cash flow | 0.35M | 0.81M | 4.67M | 2.39M | 1.43M |
| End period cash flow | 0.39M | 0.35M | 0.81M | 4.67M | 2.39M |
| Total cash from operating activities | -2.27M | -5.92M | -5.95M | -4.79M | -5.53M |
| Issuance of capital stock | 1.47M | - | - | - | - |
| Depreciation | 0.83M | 0.28M | 0.25M | 0.27M | 0.24M |
| Change to inventory | 0.21M | -0.19M | 0.15M | 0.33M | -0.21M |
| Change to account receivables | - | - | -0.15M | 0.16M | -0.66M |
| Other cashflows from financing activities | - | - | -0.31M | -0.16M | 7.02M |
| Change to netincome | - | - | 1.18M | 1.63M | 4.38M |
| Capital expenditures | 0.00M | 0.99M | 0.00M | 0.02M | 0.16M |
| Change in working capital | -0.16M | 0.20M | 0.10M | 1.03M | -0.01M |
| Stock based compensation | 0.56M | 0.49M | 1.07M | 0.77M | 2.02M |
| Other non cash items | 0.69M | 0.59M | 0.31M | 0.39M | 2.80M |
| Free cash flow | -2.27M | -6.90M | -8.10M | -4.88M | -5.70M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NURS Hydreight Technologies Inc |
-0.18 5.96% |
2.84 | 406.00 | 25.91 | 7.85 | 20.38 | 7.45 | 109.02 |
| ADK Diagnos Inc |
- -% |
0.35 | - | 10.00 | 411.24 | 18.74 | 389.06 | -6.16 |
| NXG NexgenRX Inc. |
- -% |
0.66 | 39.00 | 32.68 | 1.55 | 4.64 | 1.39 | 7.84 |
| PTEC Principal Technologies Inc |
- -% |
0.32 | - | - | 62.75 | 355.42 | 72.08 | -0.81 |
Newtopia Inc. operates as a tech-enabled whole health platform primarily in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. Newtopia Inc. was incorporated in 2008 and is headquartered in Toronto, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jeffrey Ruby J.D. | Founder, CEO & Chairman | 1975 |
| Ms. Lara Dodo | Chief Growth Officer & COO | NA |
| Mr. William J. Van Wyck | CTO & Head of Product | 1966 |
| Mr. Peter Seider | Chief Information, Privacy & Security Officer and Head of Technology Operations | 1968 |
| Mr. Edmond Lem | Controller & Sr. VP of Fin. | 1966 |
| Mr. Collin Swenson | Chief Financial Officer | NA |
| Mr. Rob Halpern | Sr. VP of Marketing | NA |
| Dr. Karyn Hood C. Psych, Ph.D. | Head of Behavioral & Mental Health | NA |
| Ms. Rikki Bennie | Sr. VP (Leave of Absence) | 1954 |
| Dr. Michele Dodds | Sr. VP of Client & Participant Success | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.